References
Rossier AB, Bussat P, Infante F, Zender R, Courvoisier B, Muheim G, Donath A, Vasey H, Taillard W, Lagier R, Gabbiani G, Baud CA, Pouzeat JA, Very JM, Hachen HJ (1973) Current facts on paraosteo-arthropathy (POA). Paraplegia 11:36–78
Chantraine A, Minaire P (1981) Para-osteo-arthropathies: a new theory and mode of treatment. Scand J Rehab Med 13:31–37
Miller LF, O'Neill CJ (1949) Myositis ossificans in paraplegics. J Bone Joint Surg 31A:283–294
Stoikovic JP, Bonfiglio M, Paul WD (1955) Myositis ossificans complicating poliomyelitis. Arch Phys Med Rehab 36:236–243
Mendelson L, Grosswasser Z, Najenson T, Sandbank U, Solzi P (1975) Periarticular new bone formation in patients suffering from severe head injuries. Scand J Rehab Med 7:141–145
Radt P (1970) Periarticular ectopic ossification in hemiplegics. Geriatrics 25:142–57
Prakash V, Lin MS, Perkash I (1978) Detection of heterotopic calcification with99m Tc-pyrophosphate in spinal cord injury patients. Clin Nucl Med 3:167–169
Brooker AF, Bowerman JW, Robinson RA, Riley LH (1973) Ectopic ossification following total hip replacement: incidence and method of classification. J Bone Joint Surg 57A:1629–1632
Jowsey J, Coventry MB, Robins PR (1977) Heterotopic ossification: theoretical consideration, possible etiologic factors, and a clinical review of total hip arthroplasty patients exhibiting this phenomenon. in: The Hip, CV Mosby, St. Louis, MO, pp 210–221
Morrey BF, Adams RA, Cabanela ME (1984) Comparison of heterotopic bone after anterolateral, transtrochanteric, and posterior approaches for total hip arthroplasty. Clin Orthop 188:160–167
Nollen, AJG, Sloof TJJH (1973) Para-articular ossifications after total hip replacement. Acta Orthop Scand 44:230–241
Evans EB (1966) Orthopaedic measures in the treatment of severe burns. J Bone Joint Surg 48A:643–669
Orzel JA, Rudd TG (1985) Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med 26:125–132
Burtis WJ, Lang R (1984) Chemical abnormalities. Orthop Clin N Am 15:653–669
Kjaersgaard-Andersen P, Pedersen P, Kristensen SS, Schmidt SA, Pedersen NW (1988) Serum alkaline phosphatase as an indicator of heterotopic bone following total hip arthroplasty. Clin Orthop 234:102–109
Freed JH, Hahn H, Menter R, Dillon T (1982) The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of didronel therapy Paraplegia 20:208–216
McClelland SJ, Rudolf LM (1986) Myositis ossificans following porous-ingrowth total knee replacement. Orthop Res 15:223–227
Kjaersgaard-Andersen P, Frich LH, Sojbjerg JO, Sneppen O (1989) Heterotopic bone formation following total shoulder arthroplasty. J Arthroplasty 4:99–104
Peters WJ, Pritzker KP (1985) Massive heterotopic ossification in breast implant capsules. Aesth Plastic Surg 9:43–45
Myers MA, Minton JP (1989) Heterotopic ossification within the small bowel mesentery. Arch Surg 124:982–983
Kromann-Anderson C, Sorensen TS, Hougaard K, Zdravkovic D, Frigaard E (1980) Ectopic bone formation following Charnley hip arthroplasty. Acta Orthop Scand 51:633–638
Ahrengart L, Lindgren U (1989) Functional significance of heterotopic bone formation after total hip arthroplasty. J Arthroplasty 4:125–131
Ritter MA, Vaughan RB (1977) Ectopic ossification after total hip arthroplasty; predisposing factors, frequency and effect on results. J Bone Joint Surg 59A:345–351
DeLee J, Ferrari A, Charnley J (1976) Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 121:53–59
Sundaram NA, Murphy JC (1986) Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis. Clin Orthop 207:223–226
Fahrer H, Koch P, Ballmer P, Enzler P, Gerber N (1988) Ectopic ossification following total hip arthroplasty: Is diffuse idiopathic skeletal hyperostosis a risk factor? Br J Rheumatol 27:187–190
Blasingame JP, Resnick D, Coutts RD, Danzig LA (1981) Extensive spinal osteophytosis as a risk factor for heterotopic bone formation after total hip arthroplasty. Clin Orthop 161:191–197
An HS, Ebraheim N, Kim K, Jackson W, Kane JT (1987) Heterotopic ossification and pseudoarthritis in the shoulder following encephalitis: a case report and review of the literature. Clin Orthop 219:291–298
Lorber I (1953) Ectopic ossification in tuberculous meningitis. Arch Dis Child 28:98–103
Ishikawa K, Izumi K, Kitagawa T (1982) Heterotopic ossification of the hip as a complication of tetanus. Clin Orthop 166:249–255
Roberts PH (1968) Heterotopic ossification complicating paralysis of intracranial origin. J Bone Joint Surg 50B:70–77
Radt P (1970) Periarticular ectopic ossification in hemiplegics. Geriatrics 25:142–157
Roberts JB, Pankratz DG (1979) The surgical treatment of heterotopic ossification at the elbow following long-term coma. J Bone Joint Surg 61A:760–763
Garland DE (1988) Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain-injured populations. Clin Orthop 233:86–101
Garland DE, O'Hallaren RM (1982) Fractures and dislocations about the elbow in the head-injured adult. Clin Orthop 168:38–41
Spencer RF (1987) The effect of head injury on fracture healing. J Bone Joint Surg 69B:525–528
Binder SM, Rubins IM, Desjardins JV, Zukor DJ, Goltzman D (1990) Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg 72A:1144–1149
Garland DE, Shimoyama ST, Lugo C, Barras D, Gilgoff I (1989) Spinal cord insults and heterotopic ossification in the pediatric population. Clin Orthop 245:303–310
Scher AT (1976) The incidence of ectopic bone formation in posttraumatic paraplegic patients of different racial groups. Paraplegia 14:202–206
Lal S, Hamilton BB, Heinemann A, Betts HB (1981) Risk factors for heterotopic ossification in spinal cord injury. Arch Phys Med Rehab 70:291–292
Hassard GH (1975) Heterotopic bone formation about the hip and unilateral decubitus ulcers in spinal cord injury. Arch Phys Med Rehab 56:355–358
Ackerman LV (1958) Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans). J Bone Joint Surg 40A:279–298
Johnson JTH (1957) Atypical myositis ossificans. J Bone Joint Surg 31A:189–194
Boyd BM Jr, Roberts WM, Miller GR (1959) Periarticular ossification following burns. South Med J 52:1048–1051
Peterson SL, Mani MM, Crawford CM, Neff JR, Hiebert JM (1989) Postburn heterotopic ossification: insights for management decision making. J Trauma 29:365–369
Evans EB (1978) Musculoskeletal changes complicating burns. In: Epps CH Jr (ed) Complications in orthopaedic surgery. JB Lippincott Co, Philadelphia
Munster AM, Bruck HM, Johns LA, VonPrince K, Kirkman E, Remig RL (1973) Heterotopic calcification following burns: a prospective study. J Trauma 12:1071–1074
Schiele HP, Hubbard RB, Bruck HM (1972) Radiographic changes in burns of the upper extremity. Diagn Radiol 104:13–17
Hoffer MM, Brody G, Ferlic F (1978) Excision of heterotopic ossification about elbows in patients with thermal injury. J Trauma 18:667–670
Bhatia NN, Hoshiko MG (1982) Uterine osseus metaplasia. Obstet Gynecol 60:256–259
Jackson DW, Feagin JA (1973) Quadriceps contusions in young athletes: relation of severity of injury to treatment and prognosis. J Bone Joint Surg 55A:95–105
Symeonides PP, Ioannides G (1972) Ossicles in the knee menisci. J Bone Joint Surg 54A:1288–1292
Jones BV, Ward MW (1980) Myositis ossificans in the biceps femoris muscles causing sciatic nerve palsy: a case report. J Bone Joint Surg 64B:506–507
Deutch I (1971) Myositis ossificans: complications of drug abuse. JAMA 216:1035
Coventry MB, Scanlon PW (1981) The use of radiation to discourage ectopic bone. J Bone Joint Surg 63A:201–208
Ayers DC, Evarts CM, Parkinson JR (1986) The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg 68A:1423–1429
Brunner R, Morscher E, Hunig R (1987) Para-articular ossification in total hip replacement: an indication for irradiation therapy. Arch Orthop Trauma Surg 106:102–107
Konski A, Weiss C, Rosier R, Poulter C, Pelligrini V, Anthony P, Evarts CM, Richardson M, Henzler M, Rubin P (1990) The use of postoperative irradiation for the prevention of heterotopic bone after total hip replacement with biologic fixation (porous coated) prosthesis: an animal model. Int J Radiat Oncol Biol Phys 18:861–865
Konski A, Pellegrini V, Poulter C, DeVanny J, Rosier R, Evarts CM, Henzler M, Rubin P (1990) Randomized trial comparing single dose versus fractionated irradiation for prevention of heterotopic bone: a preliminary report. Int J Radiat Oncol Biol Phys 18:1139–1142
Schmidt SA, Kjaersgaard-Anderson P, Pederson NW, Kristensen SS, Pedersen P, Nielsen JB (1988) The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg 770A:834–838
Elmstedt E, Lindholm TS, Nilsson OS, Tornkvist H (1985) Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 56:25–27
Fliesch HA, Russell RGG, Bisaz S, Muhlebauer RC, Williams DA (1970) The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1:12–18
Plasmans CM, Kuypers W, Sloof T (1978) The effect of ethane-1-hydroxy-1, 1-diphosphonic acid (EHDP) on matrix-induced ectopic bone formation. Clin Orthop 132:233–243
Thomas BJ, Amstutz JC (1985) Results of the administration of diphosphonates for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg 67A:400–404
Nijweide PJ, Burger EH, Feyen JH (1986) Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev 66:855–886
Gothlin G, Ericsson JLE (1976) The osteoclast: review of ultrastructure, origin, and structure-function relationship. Clin Orthop 120:201–231
Friedenstein AJ (1972) Determined and inducible osteogenic precursor cells. CIBA Foundation symposia, vol. 11 Hard tissue growth, repair and remineralization London, England pp 169–185
Puzas JE (1990) The osteoblast. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Am Soc Bone Min Res: Kelseyville, CA
Pardee AB, Dubrow R, Hamlin JL, Kletzein RF (1978) Animal cell cycle. Ann Rev Biochem 47:715–750
Zetterberg A, Larsson O (1985) Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of swiss 3T3 cells. Proc Natl Acad Sci 82:5365–5369
Tobey RA, Ley KD (1970) Regulation of initiation of DNA synthesis in chinese hamster cells. I. Production of stable reversible G1-arrested populations in suspension culture. J Cell Biol 46:151–7
Zetterberg A, Aver G (1970) Proliferative activity and cytochemical properties of nuclear chromatin related to local cell density of epithelial cells. Exp Cell Res 62:262–270
Owens GK, Geisterfer AAT, Yang YW, Komoria A (1988) Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol 107:771–780
Pledger WJ, Stiles GD, Antoniades HN, Scher CD (1977) Induction of DNA synthesis in balb/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci 74:4481–4485
Wice B, Milbrandt J, Glaser L (1987) Control of muscle differentiation in BC3HI cells by fibroblast growth factor and vandate. J Biology Chem 262:1810–1817
Kojima I, Kitaoka M, Ogata E (1990) Studies on the cycle dependency of the actions of insulin-like growth factor 1 in Balb/c 3T3 cells. J Cell Phys 143:529–533
Nishimoto I, Hata Y, Ogata E, Kojima I (1987) Insulin-like growth factor II stimulates calcium influx in competent Balb/c 3T3 cells primed with epidermal growth factor. J Biol Chem 262:12120–12126
Chambard J, Pouyssegur J (1988) TGF-β inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting early mitogenic events. J Cell Phys 135:101–107
Westermark B, Heldin C (1985) Similar action of plateletderived growth factor in the pre-replicative phase of human fibroblasts suggests a common intracellular pathway. J Cell Phys 124:43–48
O'Keefe EJ, Pledger WJ (1983) A model of cell cycle control: sequential effects regulated by growth factors. Mol Cell Endocrinol 31:167–186
Hauschka PV, Mavarakos AE, Iafrati MD, Doleman SE, Klagsbrun M (1986) Growth factors in bone matrix: isolation of multiple types by affinity chromatography on heparinsepharose. J Biol Chem 261:12665–12674
Canalis E, Raisz LG (1979) Effect of epidermal growth factor in bone formation in vitro. Endocrinology 104:862–869
Centrella M, Canalis E (1985) Local regulators of skeletal growth: a perspective. Endocr Rev 6:544–551
Centrella M, Massague J, Canalis E (1987) Transforming growth factor-β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869–2874
Rosier RN, O'Keefe RJ, Crabb ID, Puzas JE (1989) Transforming growth factor beta: an autocrine regulator of chondrocytes. Connect Tissue Res 20:295–301
Urist MR, Strates BS (1970) Bone formation in implants of partially and wholly demineralized bone matrix. Clin Orthop 71:271–278
Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P, Luxenberg DP, McQuaid D, Moutsatsos JK, Nove J, Wozney JM (1990) Recombinant human bone morphogenic protein induces bone formation. Proc Natl Acad Sci 87:2220–2224
Vukiceuk S, Luyten FP, Reddi AH (1990) Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cultures (MC3T3-E1). Biochem Biophys Res Comm 166:750–756
Seyedin SM (1989) Osteoinduction: a report on the discovery and research of unique protein growth factors mediating bone development. Oral Surg Oral Med Oral Pathol 68:527–530
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534
Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin GR, (1982) Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Biol 92:584–588
Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 165:251–256
Firschein HE, Urist MR (1972) Enzyme induction, accumulation of collagen, and calcification in implants of bone matrix. Clin Orthop 84:263–275
Canalis E, Centrella M, McCarthy T (1988) Effects of basic fibroblast growth factor on bone formation in vivo. J Clin Invest. 81:1572–7
Canalis E (1981) Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. Metabolism 30:970–975
Hock JM, Centrella M, Canalis E (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 122:254–260
Mohan S, Jennings JC, Linkhart TA, Baylink DJ (1988) Primary structure of human skeletal growth factor: sequence homology with human insulin-like growth factor-II. Biochem Biophys Acta 996:44–55
Ingber DE, Folkman J (1989) Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracelluar matrix. J Cell Biol 109:317–303
Merwin JR, Anderson JM, Kocher O, Van Italle CM, Madri JA (1990) Transforming growth factor beta I modulates extracelluar matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Phys 141:117–128
Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB (1985) Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci 82:119–123
Chen TL, Mallory JB, Chang SI (1989) Modulation of transforming growth factor-β actions in rat osteoblast-like cells: the effects of bFGF and EGF. Growth Factors 1:335–345
Pfeilschifter J, Oechsner M, Naumann A, Gronwald RGK, Minne HW, Ziegler R (1990) Stimulation of bone matrix appostion in vitro by local growth factors: a comparison between insulin-like growth factor 1, platelet-derived growth factor, and transforming growth factor β. Endocrinology 127:69–75
Puzas JE, Brand JS, Evarts CM (1987) The stimulus for bone formation. In: Brand RA (ed) The hip. CV Mosby, St Louis, pp 25–38
Puzas JE, Harper KD, Gelb DA, Alioto RJ, Sawyer JR, Rosier RN (1990) Growth factor content of pathological bone may be a determining factor for control of its mass. J Bone Mineral Res 5(suppl 2):s150
Chalmers J, Gray DH, Rush J (1975) Observations on the induction of bone in soft tissues. J Bone Joint Surg 57B:36–45
Rodan SB, Wesolowski G, Thomas K, Rodan GA (1987) Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. Endocrinology 12:1917–1923
Scher CD, Stone ME (1979) Platlet-derived growth factor prevents G0 growth arrest. Nature 281:390–392
Riegler HF, Harris CM (1976) Heterotopic bone formation after total hip arthroplasty. Clin Orthop 117:209–221
Dejerine M, Ceillier A, Dejerine Y (1919) Para-osteo-arthropathies des paraplegiques par lesions medullaires. Rev Neurol 34:399–407
Soule AB (1945) Neurogenic ossifying fibromyopathies. A preliminary report. J Neurosurg 2:485–497
Hardy AG, Dickson JW (1963) Pathological ossification in traumatic paraplegia. J Bone Joint Surg 45B:76–87
Hernandez AM, Forner JV, Fuente T, Gonzalez C, Miro R (1978) The para-articular ossifications in our paraplegics and tetraplegics: a survey of 704 patients. Paraplegia 16:272–275
Blane CE, Perkash I (1981) True heterotopic bone in the paralyzed patient. Skel Radiol 7:21–25
Lazansky M (1973) Complications revisited: the debit side of total hip replacement. Clin Orthop 95:96–103
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawyer, J.R., Myers, M.A., Rosier, R.N. et al. Heterotopic ossification: Clinical and cellular aspects. Calcif Tissue Int 49, 208–215 (1991). https://doi.org/10.1007/BF02556120
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02556120